S. Korean gov’t says no concerns over distribution of AstraZeneca vaccine
- 3 years ago
아스트라제네카 백신 생산 차질 생기나…정부 “국내 공급 문제없다”
In light of this, the Korean government announced plans to secure vaccines for 44 million people.
Health authorities said today that despite possible delays in the UK, procuring AstraZeneca's COVID-19 vaccines for local distribution will be carried out without a glitch.
Choi Won-jong reports.
The South Korean health authorities said in their briefing Wednesday... that distributing the vaccine developed by AstraZeneca will not be a major hurdle when the time comes.
There have been reports that manufacturing of the vaccine in the UK could face delays.
But the South Korean officials said that will not be the case here... because the AstraZeneca vaccine will be produced in South Korea, and those are the doses that will be distributed first.
The South Korean firm SK Bioscience agreed in July to manufacture the AstraZeneca vaccine once it's ready.
There are still questions about the vaccine, however, possibly suggesting the need for more trials.
The vaccine was shown to be 70 percent effective overall.
But among some patients in the third phase of trials... it was 90 percent effective.
This is because they were mistakenly given half a dose... followed by a full dose, while efficacy was lower among other patients was who got two full doses.
In the meantime, Seoul's health ministry has announced deals with four drugmakers to secure 64 million doses, which is enough for 34 million people.
20 million doses will be of the AstraZeneca vaccine, which will be ready as soon as February.
South Korea has not announced, however, when the actual vaccinations will start.
Choi Won-jong, Arirang News.
In light of this, the Korean government announced plans to secure vaccines for 44 million people.
Health authorities said today that despite possible delays in the UK, procuring AstraZeneca's COVID-19 vaccines for local distribution will be carried out without a glitch.
Choi Won-jong reports.
The South Korean health authorities said in their briefing Wednesday... that distributing the vaccine developed by AstraZeneca will not be a major hurdle when the time comes.
There have been reports that manufacturing of the vaccine in the UK could face delays.
But the South Korean officials said that will not be the case here... because the AstraZeneca vaccine will be produced in South Korea, and those are the doses that will be distributed first.
The South Korean firm SK Bioscience agreed in July to manufacture the AstraZeneca vaccine once it's ready.
There are still questions about the vaccine, however, possibly suggesting the need for more trials.
The vaccine was shown to be 70 percent effective overall.
But among some patients in the third phase of trials... it was 90 percent effective.
This is because they were mistakenly given half a dose... followed by a full dose, while efficacy was lower among other patients was who got two full doses.
In the meantime, Seoul's health ministry has announced deals with four drugmakers to secure 64 million doses, which is enough for 34 million people.
20 million doses will be of the AstraZeneca vaccine, which will be ready as soon as February.
South Korea has not announced, however, when the actual vaccinations will start.
Choi Won-jong, Arirang News.